Phase 1 updated exploration and first expansion data for DLL3-targeted T-cell engager tarlatamab in small cell lung cancer Meeting Abstract
| Authors: | Borghaei, H.; Paz-Ares, L.; Johnson, M.; Champiat, S.; Owonikoko, T.; Lai, V.; Boyer, M.; Hummel, H. D.; Govindan, R.; Steeghs, N.; Blackhall, F.; Reguart, N.; Dowlati, A.; Zhang, Y.; Hashemi Sadraei, N.; Goldrick, A.; Izumi, H. |
| Abstract Title: | Phase 1 updated exploration and first expansion data for DLL3-targeted T-cell engager tarlatamab in small cell lung cancer |
| Meeting Title: | 2022 World Conference on Lung Cancer |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 17 |
| Issue: | 9 Suppl. |
| Meeting Dates: | 2022 Aug 6-9 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-09-01 |
| Start Page: | S33 |
| Language: | English |
| DOI: | 10.1016/j.jtho.2022.07.062 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: OA12.05 -- Located within section named "OA12 Novel And Combination Strategies For SCLC" -- Source: Cinahl |
